prodcode,dmdcode,gemscriptcode,therapyevents,productname,ingredient,strength,formulation,routeofadministration,bnftext,v12,v13,v14,v15,v16,v17,v18,v19,v20,v21,slashcountinchapter,bnfchapter
9206,538111000001106,71994020,8940,Manerix 150mg tablets (Mylan),Moclobemide,150mg,Tablet,Oral,Reversible Monoamine-Oxidase Inhibitors,February 2009,6240001,,,,,,,,,0,4030201
67305,1.52329110000e+16,3800020,66,Moclobemide 150mg tablets (Sigma Pharmaceuticals Plc),Moclobemide,150mg,Tablet,Oral,Reversible Monoamine-Oxidase Inhibitors,August 2016,3800020,,,,,,,,,0,4030201
2883,321913005,72031020,60008,Moclobemide 150mg tablets,Moclobemide,150mg,Tablet,Oral,Reversible Monoamine-Oxidase Inhibitors,February 2009,6250001,,,,,,,,,0,4030201
5187,321915003,72032020,27287,Moclobemide 300mg tablets,Moclobemide,300mg,Tablet,Oral,Reversible Monoamine-Oxidase Inhibitors,February 2009,6250002,,,,,,,,,0,4030201
41747,823011000001104,63795020,45,Moclobemide 150mg tablets (Teva UK Ltd),Moclobemide,150mg,Tablet,Oral,Reversible Monoamine-Oxidase Inhibitors,March 2010,3938009,,,,,,,,,0,4030201
5832,48311000001107,71995020,1559,Manerix 300mg tablets (Mylan),Moclobemide,300mg,Tablet,Oral,Reversible Monoamine-Oxidase Inhibitors,February 2009,6240002,,,,,,,,,0,4030201
